Sellas Life Sciences
Price & Volume
Stats
See more52W Range | $0.77-$1.84 |
Market Cap | $102.6M |
Shares Short | 8M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | -82.5% |
Gross Profit (12 Mos) | $900,000 |
Diluted EPS | -$0.50 |
News
See moreYahoo Finance • 5 days ago
SELLAS Announces Positive Overall Survival in Cohort 3 from the Ongoing Phase 2 Trial of SLS009 in r/r AML
Yahoo Finance • 23 days ago
SELLAS Life Sciences Reports Full Year 2024 Financial Results and Provides Corporate Update
Yahoo Finance • 2 months ago
SELLAS Announces Positive Data from Phase 2a Trial of SLS009 in Combination with Zanubrutinib in DLBCL
Yahoo Finance • 2 months ago
SELLAS Life Sciences Group Announces $25 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
About
CEO | Dr. Angelos M. Stergiou M.D., ScD h.c. |
CFO | Mr. John Thomas Burns CPA |
Address | Times Square Tower, New York, NY, United States, 10036 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 15 |
